Koers OncoVista Innovative Therapies, Inc.
Aandelen
OVIT
US68232J1051
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0001 USD | -.--% |
|
-.--% | -.--% |
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 1,3 mln. 1,21 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -1 mln. -934K | Nettowinst (verlies) 2014 | -2 mln. -1,87 mln. | EV/omzet 2013 | - |
Nettoliquiditeiten 2013 | 44,9K 41,95K | Nettoschuld 2014 | 196K 183K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-0,75
x | K/w-verhouding 2014 |
-0,51
x | Werknemers | 2 |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
![Extreem 0.0001](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 16-08-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 16-08-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 2,36K | |
+40,80% | 55,66 mld. | |
-8,05% | 38,98 mld. | |
+35,79% | 38,8 mld. | |
-8,98% | 27,32 mld. | |
+10,69% | 26,29 mld. | |
-16,21% | 20,25 mld. | |
+31,00% | 12,76 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 12,12 mld. |